Related Experiment Video
Updated: Jun 5, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Dose conversion coefficients for photon exposure of the human eye lens
1Physikalisch-Technische Bundesanstalt, Bundesallee 100, D-38116 Braunschweig, Germany. rolf.behrens@ptb.de
Physics in Medicine and Biology
|December 24, 2010
Summary
New calculations show updated conversion coefficients for eye lens dose from photon radiation. These findings are crucial for accurate radiation protection and monitoring, especially at lower energies.
Area of Science:
- Medical Physics
- Radiation Dosimetry
- Ophthalmology
Background:
- Epidemiological studies indicate cataract induction at eye lens doses below 500 mGy.
- Accurate monitoring of eye lens dose is critical for radiation protection.
- Existing conversion coefficients may require refinement.
Purpose of the Study:
- To calculate accurate conversion coefficients from fluence and air kerma to equivalent dose to the lens for photon radiation.
- To compare new coefficients with existing International Commission on Radiological Protection (ICRP) values.
- To assess the impact of photon energy on dose conversion.
Main Methods:
- Development of a realistic eye model with detailed lens structure.
- Calculation of conversion coefficients using the eye model for photon radiation (5 keV to 10 MeV).
- Comparison of calculated coefficients with ICRP 1996 values, considering kerma approximation.
Main Results:
- New coefficients are similar to ICRP 1996 values between 40 keV and 1 MeV.
- New values are lower by up to factors of 5 and 7 at approximately 10 keV and 10 MeV, respectively.
- Significant discrepancies observed at low and high photon energies.
Conclusions:
- Updated conversion coefficients are necessary for accurate eye lens dose assessment.
- New coefficients should be applied in pure photon fields above 1 MeV.
- ICRP 1996 values remain relevant when secondary electrons are significant.
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:16Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...